ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+25.3%
5Y CAGR+25.7%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+25.3%/yr
vs +17.4%/yr prior
5Y CAGR
+25.7%/yr
Consistent
Acceleration
+7.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.1x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $273.17M | +9.2% |
| 2024 | $250.21M | +37.8% |
| 2023 | $181.51M | +30.8% |
| 2022 | $138.78M | +37.9% |
| 2021 | $100.61M | +15.4% |
| 2020 | $87.16M | +38.0% |
| 2019 | $63.15M | -13.5% |
| 2018 | $73.02M | -7.6% |
| 2017 | $79.03M | +62.0% |
| 2016 | $48.78M | - |